Abstract Library

#3774 The role of the gut microbiome in patients with midgut neuroendocrine tumors

Introduction: When compared to other cancers, the prevalence of midgut neuroendocrine tumors (NETs) has disproportionally increased over the past decades. To date, very little progress has been made in the discovery of (epi)genetic drivers and treatment options of these tumors. Recent microbiome research has provided novel treatment targets among various cancer types. However, its role in midgut NETs and the Carcinoid Syndrome (CS), a frequently present syndrome of hormonal hypersecretion, has not been studied.

Conference:

Presenting Author:

Authors: Mulders M, Audhoe A, Kraaij R, van Koetsveld P, Feelders R,

Keywords: gut, microbiome, neuroendocrine, tumor, carcinoid, syndrome, diagnosis,

#3192 Clinical epidemiology of patients with neuroendocrine tumors (NETs) in Spain, using electronic health records (EHRs) and big data techniques

Introduction: The epidemiology and clinical features of NETs are best understood in large, population-based registries with available follow-up information. Real-word evidence and “Big Data” techniques hold potential to increase understanding of the disease and help identify new therapeutic strategies, through analysis of large clinical datasets contained in EHRs.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author:

Authors: Marazuela M, de La Cruz G, Grandoulier A, De la Puente M, López C,

Keywords: neuroendocrine tumor, big data, epidemiology, electronic health records,